On 3 April 2020, Treatment Action Group (TAG), Médecins Sans Frontières (MSF) Access Campaign, and the Global Coalition of TB Activists (GCTA) held a webinar on the price of Xpert tests for COVID-19, HIV, TB, HCV and other diseases. The webinar provided the latest information about the “Time for $5” campaign and the evidence base for why GeneXpert tests should be priced at US$5.
The video recording of the webinar and the presentation slides are now available at the following link:
The “Time for $5” campaign is a global civil society movement calling on the diagnostics company Cepheid to reduce the prices of Xpert rapid molecular tests for developing countries from $10-$20 to $5, inclusive of the cost of service and maintenance. These include tests for TB, HIV, hepatitis B & C, HPV, STIs, and now COVID-19. This $5 ask is underpinned by a cost-of-goods analysis that found the cost of manufacturing each test to be approximately $3. More information on the “Time for $5” campaign is available here, including all of the campaign correspondence with Cepheid to date.